These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 12880415

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA, Marcil I, Stern RS.
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [Abstract] [Full Text] [Related]

  • 3. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS, PUVA Follow-Up Study.
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [Abstract] [Full Text] [Related]

  • 4. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS, Liebman EJ, Väkevä L.
    J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734
    [Abstract] [Full Text] [Related]

  • 5. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I, Stern RS.
    Lancet; 2001 Sep 29; 358(9287):1042-5. PubMed ID: 11589933
    [Abstract] [Full Text] [Related]

  • 6. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY, Heinrich LA, Schultz MD, Reizner GT, Kumm RC, Cripps DJ.
    J Am Acad Dermatol; 1992 Feb 29; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [Abstract] [Full Text] [Related]

  • 7. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H, Kreimer-Erlacher H, Bäck B, Soyer HP, Höfler G, Kerl H, Wolf P.
    J Invest Dermatol; 2001 Aug 29; 117(2):365-70. PubMed ID: 11511317
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS, Bagheri S, Nichols K, PUVA Follow Up Study.
    J Am Acad Dermatol; 2002 Jul 29; 47(1):33-9. PubMed ID: 12077578
    [Abstract] [Full Text] [Related]

  • 11. [Puva therapy and carcinogenesis].
    Thomas P, Pannequin C.
    Ann Dermatol Venereol; 1991 Jul 29; 118(6-7):503-6. PubMed ID: 1897842
    [No Abstract] [Full Text] [Related]

  • 12. Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy.
    Ortiz Salvador JM, Pérez-Ferriols A, Alegre de Miquel V, Saneleuterio Temporal M, Vilata Corell JJ.
    Med Clin (Barc); 2019 Jun 21; 152(12):488-492. PubMed ID: 30503067
    [Abstract] [Full Text] [Related]

  • 13. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS, Laird N.
    Cancer; 1994 Jun 01; 73(11):2759-64. PubMed ID: 8194017
    [Abstract] [Full Text] [Related]

  • 14. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS, Nichols KT, Väkevä LH.
    N Engl J Med; 1997 Apr 10; 336(15):1041-5. PubMed ID: 9091799
    [Abstract] [Full Text] [Related]

  • 15. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization.
    Stern RS, Bolshakov S, Nataraj AJ, Ananthaswamy HN.
    J Invest Dermatol; 2002 Aug 10; 119(2):522-6. PubMed ID: 12190879
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
    Wolf P, Kreimer-Erlacher H, Seidl H, Bäck B, Soyer HP, Kerl H.
    J Invest Dermatol; 2004 Jan 10; 122(1):190-200. PubMed ID: 14962108
    [Abstract] [Full Text] [Related]

  • 18. The risk of melanoma in association with long-term exposure to PUVA.
    Stern RS, PUVA Follow up Study.
    J Am Acad Dermatol; 2001 May 10; 44(5):755-61. PubMed ID: 11312420
    [Abstract] [Full Text] [Related]

  • 19. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM.
    Arch Dermatol; 1995 Apr 10; 131(4):432-5. PubMed ID: 7726585
    [Abstract] [Full Text] [Related]

  • 20. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T, Christophers E.
    Natl Cancer Inst Monogr; 1984 Dec 10; 66():217-9. PubMed ID: 6531033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.